Clinical Trial Update: Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of BCD-201 in combination with Keytruda for advanced melanoma is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• BCD-201
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Biocad | Conditions: Melanoma (Skin) | Phase 3 | Status: UNKNOWN